Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

mTORC2 contributes to systemic autoimmunity

Immunology(2022)10.1111/imm.13594Source: DataRank Database

mTORC2 contributes to systemic autoimmunity is a research paper published in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.47)OA: greenTopics (46)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Haiyu Qi,Meilu Li ORCID,Yanfeng Li ORCID,Xingxing Zhu ORCID,Shreyasee Amin ORCID

Live enrichment

PubMed:36273262 PMC:PMC9975033 OpenAlex:https://openalex.org/W4307115934

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: R01AR077518

Lupus Research Alliance

Grant: 696599

National Institutes of Health

Grant: 5R01AR077518-04

Immune Checkpoint Inhibition and humoral immune response in systemic autoimmunity

Mayo Clinic

Mayo Foundation for Medical Education and Research

National Institutes of Health

FWCI

0.47

Citation Percentile

0.6%

Citation Trend

2023

2024

2025

2026

greenLicense: Wiley Online Library User Agreement

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9975033

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13594

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/imm.13594

journalhttps://doi.org/10.1111/imm.13594

Fields of Study

PI3K/AKT/mTOR signaling in cancerMast cells and histamineT-cell and B-cell Immunology03 medical and health sciences0302 clinical medicineMiceAnimalsAutoimmunityMechanistic Target of Rapamycin Complex 2T-Lymphocytes, Helper-InducerLupus Erythematosus, SystemicCell DifferentiationReceptors, Antigen, T-CellGlucose

MeSH Terms

Mechanistic Target of Rapamycin Complex 2AnimalsCell DifferentiationGlucoseT-Lymphocytes, Helper-InducerLupus Erythematosus, SystemicReceptors, Antigen, T-CellAutoimmunityMice

Keywords

AutoimmunityImmunologyBiologymTORC2T cellT-cell receptorCell biologyCancer researchSignal transductionPI3K/AKT/mTOR pathwayImmune systemmTORC1Regulatory T cellsT Follicular Helper CellLupus/sleMiceGlucoseReceptors, Antigen, T-CellAnimalsLupus Erythematosus, SystemicCell DifferentiationMechanistic Target of Rapamycin Complex 2T-Lymphocytes, Helper-Inducer

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being